The effect of PCSK9 inhibitors on cardiovascular outcomes in diabetic patients: a narrative review
{{output}}
Cardiovascular events are a common occurrence in patients with diabetes mellitus. Multiple pharmacological interventions have been developed to reduce cardiovascular risk in this population; however, in this review, we focus on the role of proprotein convertas... ...